Les inhibiteurs de BTK tels que l'Ibrutinib, le Zanubrutinib, etc., sont de tr\u00e8s bons m\u00e9dicaments pour le traitement de la MW, en particulier pour la MW r\u00e9cidivante et r\u00e9fractaire. Malheureusement, contrairement \u00e0 d'autres m\u00e9dicaments utilis\u00e9s dans le traitement de la MW, ils ne sont g\u00e9n\u00e9ralement pas financ\u00e9s par les provinces pour le traitement de la MW, principalement en raison de leur co\u00fbt \u00e9lev\u00e9. Ceci en d\u00e9pit du fait que la plupart de ces m\u00e9dicaments sont approuv\u00e9s par Sant\u00e9 Canada pour le traitement de la MW.<\/p>\n
Ainsi, contrairement aux autres m\u00e9dicaments utilis\u00e9s dans le traitement de la MW, le paiement de ces m\u00e9dicaments devient un probl\u00e8me.<\/p>\n
Nous avons r\u00e9pondu \u00e0 la question \"Comment g\u00e9rer les co\u00fbts des inhibiteurs de BTK\" dans une nouvelle question ajout\u00e9e \u00e0 notre liste de questions. R\u00e9ponses aux questions les plus fr\u00e9quentes des patients canadiens<\/a> page.<\/p>","protected":false},"excerpt":{"rendered":" BTK Inhibitor drugs such as Ibrutinib, Zanubrutinib, etc, are very good drugs for the treatment of WM, especially for relapsed and refractory WM.\u00a0 Unfortunately, unlike other drugs used in the treatment of WM, they are currently not generally funded by the Provinces for the treatment of WM, primarily because of their high cost.\u00a0 This is despite the fact that most of these drugs are approved by Health Canada for the treatment of WM. So, unlike other drugs used in the treatment of WM, paying for these drugs becomes an issue. We have addressed the question of “How does one manage the […]<\/a><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_price":"","_stock":"","_tribe_ticket_header":"","_tribe_default_ticket_provider":"","_ticket_start_date":"","_ticket_end_date":"","_tribe_ticket_show_description":"","_tribe_ticket_show_not_going":false,"_tribe_ticket_use_global_stock":"","_tribe_ticket_global_stock_level":"","_global_stock_mode":"","_global_stock_cap":"","_tribe_rsvp_for_event":"","_tribe_ticket_going_count":"","_tribe_ticket_not_going_count":"","_tribe_tickets_list":"[]","_tribe_ticket_has_attendee_info_fields":false,"footnotes":""},"categories":[28,20],"tags":[],"class_list":["post-4944","post","type-post","status-publish","format-standard","hentry","category-canadian-insights","category-news"],"_links":{"self":[{"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/posts\/4944","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/comments?post=4944"}],"version-history":[{"count":4,"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/posts\/4944\/revisions"}],"predecessor-version":[{"id":4958,"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/posts\/4944\/revisions\/4958"}],"wp:attachment":[{"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/media?parent=4944"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/categories?post=4944"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/tags?post=4944"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}